Viewing Study NCT05015920


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-04-25 @ 11:41 PM
Study NCT ID: NCT05015920
Status: COMPLETED
Last Update Posted: 2025-05-18
First Post: 2021-06-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major Participants
Sponsor: Shanghai BDgene Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematologic Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TDT View
None β-thalassemia major View